
NOVEL is an innovative biotechnology company founded in 2004 in Novosibirsk, combining molecular biology expertise with advanced data analysis technologies. It operates globally with offices in Russia, the USA, China, and the Netherlands. The company specializes in bioinformatics, software development, and machine learning to serve biotech companies, pharmaceutical firms, scientific laboratories, diagnostic centers, and biobanks. NOVEL develops proprietary IT technologies for big data processing, cloud computing, and AI, focusing on genomic and biomedical data analysis including next-generation sequencing and medical imaging. Its team of over 50 experts includes developers, data scientists, bioinformaticians, and biologists, many with advanced degrees. NOVEL supports clients through software products like NGS Wizard for automated NGS data processing and Protomenal for protein function analysis, aiming to lead in AI-driven personalized medicine and molecular genetics markets.

NOVEL is an innovative biotechnology company founded in 2004 in Novosibirsk, combining molecular biology expertise with advanced data analysis technologies. It operates globally with offices in Russia, the USA, China, and the Netherlands. The company specializes in bioinformatics, software development, and machine learning to serve biotech companies, pharmaceutical firms, scientific laboratories, diagnostic centers, and biobanks. NOVEL develops proprietary IT technologies for big data processing, cloud computing, and AI, focusing on genomic and biomedical data analysis including next-generation sequencing and medical imaging. Its team of over 50 experts includes developers, data scientists, bioinformaticians, and biologists, many with advanced degrees. NOVEL supports clients through software products like NGS Wizard for automated NGS data processing and Protomenal for protein function analysis, aiming to lead in AI-driven personalized medicine and molecular genetics markets.